Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
CBRE: Boston Life Science Development Exceeds Pre-Pandemic Levels
The Greater Boston life sciences lab space market experienced a return to normalcy in 2022 and the first half of 2023 after a record-setting 2021, according to CBRE’s Q2 Boston Lab Figures report.
Leasing velocity in Q2 decreased to 520,000 square feet from the previous quarter’s 850,000 square feet as lab tenants reevaluated their space requirements amid economic uncertainty. However, developers are still planning for future growth, with over 17 million square feet of lab space under construction. The market saw negative absorption of 193,000 square feet and an increase in vacancy rate to 5.4%.
Asking rents remained relatively flat. The notable deal of the quarter was Orbital Therapeutics’ sublease of 166,000 square feet at 100 Binney Street in Cambridge. Capital markets activity remained subdued due to economic uncertainty and tightened lending standards.
- ◦Economy